EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quality by Design for Preclinical In Vitro Assay Development

Jonathan Jones iD, Bairu Zhang, Xiang Zhang, Peter Konings iD, Pia Hansson, Anna Backmark, Alessia Serrano, Ulrike Künzel, Steven Novick iD

Pharmaceutical Statistics · 2025

DOI: 10.1002/pst.2430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2025. Verfasst von Jonathan Jones und 8 weiteren Autor:innen. Beteiligte Einrichtung: Data Sciences and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK. Hauptthemen laut MEDLINE: Research Design, Drug Development, Biological Assay. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quality by Design (QbD) is an approach to assay development to determine the design space, which is the range of assay variable settings that should result in satisfactory assay quality. Typically, QbD is applied in manufacturing, but it works just as well in the preclinical space. Through three examples, we illustrate the QbD approach with experimental design and associated data analysis to determine the design space for preclinical assays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignDrug DevelopmentBiological AssayDrug Evaluation, PreclinicalHumansQuality ControlAnimals

Stichwörter der Autor:innen

CRISPRJMPassay optimizationdesign of experimentsdesign spacescreening

Autor:innen und Institutionen

  • Data Sciences and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Data Sciences and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
  • Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Functional Genomics, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Data Sciences and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA.

ORCID-Profile: Jonathan Jones, Peter Konings, Steven Novick

Zitieren

APA

Jones, J., Zhang, B., Zhang, X., Konings, P., Hansson, P., Backmark, A., Serrano, A., Künzel, U., & Novick, S. (2025). Quality by Design for Preclinical In Vitro Assay Development. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2430

Vancouver

Jones J, Zhang B, Zhang X, Konings P, Hansson P, Backmark A, et al. Quality by Design for Preclinical In Vitro Assay Development. Pharmaceutical Statistics. 2025. doi:10.1002/pst.2430

BibTeX
@article{Jones2025,
  author = {Jones, Jonathan and Zhang, Bairu and Zhang, Xiang and Konings, Peter and Hansson, Pia and Backmark, Anna and Serrano, Alessia and Künzel, Ulrike and Novick, Steven},
  title = {Quality by Design for Preclinical In Vitro Assay Development},
  journal = {Pharmaceutical Statistics},
  year = {2025},
  doi = {10.1002/pst.2430}
}
Kostenlos starten →